Protein Engineering Market (By Product: Reagents, Instruments; By Protein Type: Insulin, Vaccines; By End-use: CROs, Pharma & Biotech Companies; By Technology) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2023-2032

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Protein Engineering Market 

5.1. COVID-19 Landscape: Protein Engineering Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Protein Engineering Market, By Product

8.1. Protein Engineering Market, by Product, 2023-2032

8.1.1. Instruments

8.1.1.1. Market Revenue and Forecast (2019-2032)

8.1.2. Reagents

8.1.2.1. Market Revenue and Forecast (2019-2032)

8.1.3. Software & Services

8.1.3.1. Market Revenue and Forecast (2019-2032)

Chapter 9. Global Protein Engineering Market, By Technology

9.1. Protein Engineering Market, by Technology, 2023-2032

9.1.1. Rational Protein Design

9.1.1.1. Market Revenue and Forecast (2019-2032)

9.1.2. Directed Evolution

9.1.2.1. Market Revenue and Forecast (2019-2032)

9.1.3. Hybrid Approach

9.1.3.1. Market Revenue and Forecast (2019-2032)

9.1.4. De Novo Protein Design

9.1.4.1. Market Revenue and Forecast (2019-2032)

9.1.5. Others

9.1.5.1. Market Revenue and Forecast (2019-2032)

Chapter 10. Global Protein Engineering Market, By Protein Type 

10.1. Protein Engineering Market, by Protein Type, 2023-2032

10.1.1. Insulin

10.1.1.1. Market Revenue and Forecast (2019-2032)

10.1.2. Monoclonal Antibodies

10.1.2.1. Market Revenue and Forecast (2019-2032)

10.1.3. Vaccines

10.1.3.1. Market Revenue and Forecast (2019-2032)

10.1.4. Growth Factors

10.1.4.1. Market Revenue and Forecast (2019-2032)

10.1.5. Colony Stimulating Factors

10.1.5.1. Market Revenue and Forecast (2019-2032)

10.1.6. Coagulation Factors

10.1.6.1. Market Revenue and Forecast (2019-2032)

10.1.7. Interferon

10.1.7.1. Market Revenue and Forecast (2019-2032)

10.1.8. Others

10.1.8.1. Market Revenue and Forecast (2019-2032)

Chapter 11. Global Protein Engineering Market, By End-use 

11.1. Protein Engineering Market, by End-use, 2023-2032

11.1.1. Academic Research Institutes

11.1.1.1. Market Revenue and Forecast (2019-2032)

11.1.2. Contract Research Organizations

11.1.2.1. Market Revenue and Forecast (2019-2032)

11.1.3. Pharmaceutical & Biotechnology Companies

11.1.3.1. Market Revenue and Forecast (2019-2032)

Chapter 12. Global Protein Engineering Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Product (2019-2032)

12.1.2. Market Revenue and Forecast, by Technology (2019-2032)

12.1.3. Market Revenue and Forecast, by Protein Type (2019-2032)

12.1.4. Market Revenue and Forecast, by End-use (2019-2032)

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Product (2019-2032)

12.1.5.2. Market Revenue and Forecast, by Technology (2019-2032)

12.1.5.3. Market Revenue and Forecast, by Protein Type (2019-2032)

12.1.5.4. Market Revenue and Forecast, by End-use (2019-2032)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Product (2019-2032)

12.1.6.2. Market Revenue and Forecast, by Technology (2019-2032)

12.1.6.3. Market Revenue and Forecast, by Protein Type (2019-2032)

12.1.6.4. Market Revenue and Forecast, by End-use (2019-2032)

12.2. Europe

12.2.1. Market Revenue and Forecast, by Product (2019-2032)

12.2.2. Market Revenue and Forecast, by Technology (2019-2032)

12.2.3. Market Revenue and Forecast, by Protein Type (2019-2032)

12.2.4. Market Revenue and Forecast, by End-use (2019-2032)

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Product (2019-2032)

12.2.5.2. Market Revenue and Forecast, by Technology (2019-2032)

12.2.5.3. Market Revenue and Forecast, by Protein Type (2019-2032)

12.2.5.4. Market Revenue and Forecast, by End-use (2019-2032)

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Product (2019-2032)

12.2.6.2. Market Revenue and Forecast, by Technology (2019-2032)

12.2.6.3. Market Revenue and Forecast, by Protein Type (2019-2032)

12.2.6.4. Market Revenue and Forecast, by End-use (2019-2032)

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Product (2019-2032)

12.2.7.2. Market Revenue and Forecast, by Technology (2019-2032)

12.2.7.3. Market Revenue and Forecast, by Protein Type (2019-2032)

12.2.7.4. Market Revenue and Forecast, by End-use (2019-2032)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Product (2019-2032)

12.2.8.2. Market Revenue and Forecast, by Technology (2019-2032)

12.2.8.3. Market Revenue and Forecast, by Protein Type (2019-2032)

12.2.8.4. Market Revenue and Forecast, by End-use (2019-2032)

12.3. APAC

12.3.1. Market Revenue and Forecast, by Product (2019-2032)

12.3.2. Market Revenue and Forecast, by Technology (2019-2032)

12.3.3. Market Revenue and Forecast, by Protein Type (2019-2032)

12.3.4. Market Revenue and Forecast, by End-use (2019-2032)

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Product (2019-2032)

12.3.5.2. Market Revenue and Forecast, by Technology (2019-2032)

12.3.5.3. Market Revenue and Forecast, by Protein Type (2019-2032)

12.3.5.4. Market Revenue and Forecast, by End-use (2019-2032)

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Product (2019-2032)

12.3.6.2. Market Revenue and Forecast, by Technology (2019-2032)

12.3.6.3. Market Revenue and Forecast, by Protein Type (2019-2032)

12.3.6.4. Market Revenue and Forecast, by End-use (2019-2032)

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Product (2019-2032)

12.3.7.2. Market Revenue and Forecast, by Technology (2019-2032)

12.3.7.3. Market Revenue and Forecast, by Protein Type (2019-2032)

12.3.7.4. Market Revenue and Forecast, by End-use (2019-2032)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Product (2019-2032)

12.3.8.2. Market Revenue and Forecast, by Technology (2019-2032)

12.3.8.3. Market Revenue and Forecast, by Protein Type (2019-2032)

12.3.8.4. Market Revenue and Forecast, by End-use (2019-2032)

12.4. MEA

12.4.1. Market Revenue and Forecast, by Product (2019-2032)

12.4.2. Market Revenue and Forecast, by Technology (2019-2032)

12.4.3. Market Revenue and Forecast, by Protein Type (2019-2032)

12.4.4. Market Revenue and Forecast, by End-use (2019-2032)

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Product (2019-2032)

12.4.5.2. Market Revenue and Forecast, by Technology (2019-2032)

12.4.5.3. Market Revenue and Forecast, by Protein Type (2019-2032)

12.4.5.4. Market Revenue and Forecast, by End-use (2019-2032)

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Product (2019-2032)

12.4.6.2. Market Revenue and Forecast, by Technology (2019-2032)

12.4.6.3. Market Revenue and Forecast, by Protein Type (2019-2032)

12.4.6.4. Market Revenue and Forecast, by End-use (2019-2032)

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Product (2019-2032)

12.4.7.2. Market Revenue and Forecast, by Technology (2019-2032)

12.4.7.3. Market Revenue and Forecast, by Protein Type (2019-2032)

12.4.7.4. Market Revenue and Forecast, by End-use (2019-2032)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Product (2019-2032)

12.4.8.2. Market Revenue and Forecast, by Technology (2019-2032)

12.4.8.3. Market Revenue and Forecast, by Protein Type (2019-2032)

12.4.8.4. Market Revenue and Forecast, by End-use (2019-2032)

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Product (2019-2032)

12.5.2. Market Revenue and Forecast, by Technology (2019-2032)

12.5.3. Market Revenue and Forecast, by Protein Type (2019-2032)

12.5.4. Market Revenue and Forecast, by End-use (2019-2032)

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Product (2019-2032)

12.5.5.2. Market Revenue and Forecast, by Technology (2019-2032)

12.5.5.3. Market Revenue and Forecast, by Protein Type (2019-2032)

12.5.5.4. Market Revenue and Forecast, by End-use (2019-2032)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Product (2019-2032)

12.5.6.2. Market Revenue and Forecast, by Technology (2019-2032)

12.5.6.3. Market Revenue and Forecast, by Protein Type (2019-2032)

12.5.6.4. Market Revenue and Forecast, by End-use (2019-2032)

Chapter 13. Company Profiles

13.1. Agilent Technologies

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Bruker Corp.

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Thermo Fisher Scientific, Inc.

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. PerkinElmer, Inc.

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Waters Corp.

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Bio-Rad Laboratories

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Merck KGaA

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Danaher Corp.

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. Genscript Biotech Corp

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Amgen Inc.

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms